Rockwell Medical (RMTI) Appoints Joan Lau to its Board

Rockwell Medical, Inc. (Nasdaq: RMTI) today announced that the Company appointed Joan Lau, Ph.D. to its board of directors. Dr. Lau's appointment increases Rockwell Medical's board of directors to seven members.

"We are pleased to welcome Joan to Rockwell Medical's board of directors," said Robert S. Radie, Chairman of the Board of Directors at Rockwell Medical. "Joan has founded, led, and scaled a number of biotechnology companies throughout her career, possessing a significant amount of business development, operational, and M&A expertise. Additionally, her experience as a public company board member will be valuable to Rockwell Medical as the Company continues to grow its customer base and portfolio of products, to serve the needs of dialysis clinics and the patients they serve, and to position Rockwell to achieve its goal of increasing shareholder value.”

Dr. Lau has more than 20 years’ experience in executive leadership of R&D focused biopharma as an entrepreneur scientist, CEO, operator, investor, and board member of public and private biopharmaceutical companies. Currently, Dr. Lau is CEO of Spirovant, where she is responsible for the strategic direction and growth of the gene therapy company. Previously, Dr. Lau co-founded and was Managing Partner of Militia Hill Ventures, which focuses on building and growing high quality life sciences companies. Dr. Lau led several biotech companies including Azelon Pharmaceuticals as President and CEO; Locus Pharmaceuticals; and Immunome as COO. Additionally, she served as a director of Renovacor (NYSE: RCOR) until its acquisition by Rocket Pharmaceuticals and began her biopharmaceutical career at Merck Research Laboratories.

Engaged in the Philadelphia community, Dr. Lau serves on the Boards of Trustees for the University of Pennsylvania, Brandywine Realty Trust (NYSE: BDN), and the Philadelphia Orchestra. Dr. Lau earned a MBA from the Wharton School of Business and a BSE in Bioengineering, both at the University of Pennsylvania, and a Ph.D. in Neuroscience from the University of Cincinnati College of Medicine.

You May Also Be Interested In

• Citadel unwinds 80% of Aschenbrenner’s portfolio risk - report
• loanDepot receives NYSE non-compliance notice over stock price
• Home Depot expands executive roles, grants $500K in restricted stock